Aspirin sensitivity and desensitization for asthma and sinusitis

Current Allergy and Asthma Reports

Volumn 9, Issue 2, 2009, Pages 155-163

  Stevenson, Donald D ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CELECOXIB; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FENOPROFEN; IMMUNOGLOBULIN E; KETOROLAC; LEUKOTRIENE RECEPTOR AFFECTING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MELOXICAM; MONTELUKAST; NABUMETONE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROSTAGLANDIN E2; SALBUTAMOL; SALSALATE; UNINDEXED DRUG; ZAFIRLUKAST; ZILEUTON;

ADJUVANT THERAPY; ALLERGIC RHINITIS; ANAPHYLAXIS; ANOSMIA; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CLINICAL TRIAL; COMPETITIVE INHIBITION; CROSS REACTION; CYTOKINE RELEASE; DESENSITIZATION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RECHALLENGE; FLUSHING; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; HYPOTENSION; IMMUNOTHERAPY; INTENSIVE CARE; LACRIMATION DISORDER; LARYNX SPASM; MONOTHERAPY; MUCOSA INFLAMMATION; NOSE CONGESTION; NOSE POLYP; OCULAR PRURITUS; PATHOGENESIS; PREVALENCE; PROSTAGLANDIN SYNTHESIS; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHINORRHEA; SIDE EFFECT; SINUSITIS; SKIN TEST; STOMACH PAIN; URTICARIA; VIRAL RESPIRATORY TRACT INFECTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; CYCLOOXYGENASE INHIBITORS; DRUG HYPERSENSITIVITY; HUMANS; SINUSITIS;

EID: 60349097968     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-009-0023-4     Document Type: Review

References (50)

1. Widal MF, Abrami P, Lermeyez J: Idiosyncratic anaphylaxis [in French]. Presse Med 1922, 30:189-192.
2. Samter M, Beers R Cr: Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968, 68:975-983.
3. Stevenson D, Simon RR, Zuraw BL: Sensitivity to aspirin and NSAIDs. In Middleton's Allergy Principles and Practice, edn 6. Edited by Adkinson NJ, Yunginger JW, Busse WW, et al. Philadelphia: CV Mosby and Co.; 2003:1695-1710.
4. Johannessen S, Bieber T, Dahl R, et al.: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832-836.
5. Stevenson D, Szczeklik A: Current and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006, 118:773-786.
6. Berges-Gimeno M, Simon RA, Stevenson DD: The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002, 89:474-478.
7. Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000, 16:432-436.
8. Jenkins C, Costello J, Hodge L: Systematic review of prevalence of aspirin-induced asthma and its implications for clinical practice. BMJ 2004, 328:434-437.
9. Delaney JC: The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy 1976, 6:177-181.
10. Dursun AB, Woessner KA, Simon RA, et al.: Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps and chronic sinusitis. Ann Allergy Asthma Immunol 2008, 100:420-425.
11. Weber RW, Hoffman M, Raine DA, Nelson HS: Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol 1979, 64:32-37.
12. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977, 60:276-284.
13. Settipane RA, Stevenson DD: Cross sensitivity with acetaminophen in aspirin sensitive asthmatics. J Allergy Clin Immunol 1989, 84:26-33.
14. Stevenson DD, Hougham A, Schrank P, et al.: Disalcid cross-sensitivity in aspirin sensitive asthmatics. J Allergy Clin Immunol 1990, 86:749-758.
15. Bavbek S, Celik G, Ediger D, et al.: The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance. J Asthma 1999, 36:657-663.
16. Vaghi A: Tolerance of meloxicam in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1998, 157:715.
17. Gyllfors P, Bochenek G, Overholt J, et al.: Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 2003, 111:1116-1121.
18. Stevenson D, Simon RA: Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J Allergy Clin Immunol 2001, 108:47-51.
19. Szczeklik A, Nizankowska E, Bochenek G, et al.: Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001, 31:219-225.
20. Woessner K, Simon RA, Stevenson DD: The safety of celecoxib in aspirin exacerbated respiratory disease. Arthritis Rheum 2002, 46:2201-2206.
21. Levy MB, Fink JN: Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 2001, 87:72-73.
22. Baldassarre S, Schandene L, Choufani G, Michils A: Asthma attacks induced by low doses of celecoxib, aspirin and acetaminophen. J Allergy Clin Immunol 2006, 117:215-217.
23. Stevenson DD: Anaphylactic and anaphylactoid reactions to aspirin and nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 2001, 21:745-768.
24. Stevenson DD: Oral challenges to detect aspirin and sulfite sensitivity in asthma. N Engl Reg Allergy Proc 1988, 9:135-142.
25. Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A: Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000, 15:863-869.
26. Micheletto C, Tognella S, Visconti M, et al.: Changes in urinary LTE4 and nasal function following nasal provocation tests with ASA-tolerant and intolerant asthmatics. Respir Med 2006, 100:2144-2150.
27. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A: Nasal provocation test with lysine-aspirin for diagnosis of aspirinsensitive asthma. J Allergy Clin Immunol 1998, 101:581-586.
28. Berges-Gimeno MP, Simon RA, Stevenson DD: The effect of leukotriene modifier drugs on ASA-induced asthma and rhinitis reactions. Clin Exp Allergy 2002, 32:1491-1496.
29. White A, Ludington E, Mehra P, et al.: Effect of leukotriene modifier drugs on the safety of OACs. Ann Allergy Asthma Immunol 2006, 97:688-693.
30. White A, Bigby TA, Stevenson DD: Intranasal ketorolac challenge for the diagnosis of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2006, 97:190-195.
31. Williams A, Simon RA, Woessner KM, Stevenson DD: The relationship between historical aspirin-induced asthma and the severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol 2007, 120:273-277.
32. Szczeklik A: Aspirin-induced asthma as a viral disease. Clin Allergy 1988, 18:15-20.
33. Davoine F, Cao M, Wu Y, et al.: Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells. J Allergy Clin Immunol 2008, 122:69-77.
34. Daffern P, Muilenburg D, Hugli TE, et al.: Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 1999, 104:559-564.
35. Szczeklik A, Sladek K, Dworski R, et al.: Bronchial aspirin challenge causes specific eicosanoid response in aspirinsensitive asthmatics. Am J Respir Crit Care Med 1996, 154:1608-1614.
36. Sanak M, Szczeklik A: Leukotriene C4 synthase polymorphism and aspirin-induced asthma. J Allergy Clin Immunol 2001, 107:561-562.
37. Sousa A, Parikh A, Scadding G, et al.: Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002, 347:1524-1526.
38. Bochenek G, Nagraba K, Nizankowska E, Szczeklik A: A controlled study of 9alpha11beta-PGF2 (a PGD2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenges. J Allergy Clin Immunol 2003, 111:743-749.
39. Powell W: A novel PGD2 receptor expressed in eosinophils. Prostaglandins Leukot Essent Fatty Acids 2003, 69:179-185.
40. Szczeklik A, Sanak M: The broken balance in aspirin hypersensitivity. Eur J Pharmacol 2006, 533:145-155.
41. Kowalski ML, Sliwinska-Kowalska M, Igarashi Y, et al.: Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol 1993, 91:580-598.
42. Szczeklik A: Prostaglandin E2 and aspirin-induced asthma [letter, comment]. Lancet 1995, 345:1056.
43. Sestini P, Armetti L, Gambaro G, et al.: Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996, 153:572-575.
44. Dahlen B, Nizankowska E, Szczeklik A, et al.: The benefits of adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Resp Crit Care Med 1998, 157:1187-1194.
45. Dahlen S, Malstrom K, Nizankowska E, et al.: Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist. A randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2002, 165:9-14.
46. Amar YG, Frenkiel S, Sobol SE: Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad. J Otolaryngol 2000, 29:7-12.
47. Sweet JA, Stevenson DD, Simon RA, Mathison DA: Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma. J Allergy Clin Immunol 1990, 86:59-65.
48. Berges-Gimeno M, Simon RA, Stevenson DD: Treatment with aspirin desensitization in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol 2003, 111:180-186.
49. Stevenson DD, Hankammer MA, Mathison DA, et al.: Long term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J Allergy Clin Immunol 1996, 98:751-758.
50. Stevenson D, Simon RA: Selection of patients for aspirin desensitization. J Allergy Clin Immunol 2006, 116:801-804.